| Y-o-Y | REVENUES | OPERATING MARGIN | PROFIT AFTER TAX | EPS | ROCE | Details👇 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.2% |
1.5% |
7.4% |
| SENSEX | 2.7% |
7.3% |
54.2% |
| Consolidated | Mar2021 | Mar2020 | Mar2019 | Mar2018 | Mar2017 |
|---|---|---|---|---|---|
| Revenues | ₹8,005 Cr | ₹7,939 Cr | ₹7,673 Cr | ₹5,950 Cr | ₹5,816 Cr |
| Expenses | ₹5,538 Cr | ₹5,769 Cr | ₹5,696 Cr | ₹4,601 Cr | ₹4,438 Cr |
| Operating Profit (Excl OI) | ₹2,467 Cr | ₹2,170 Cr | ₹1,976 Cr | ₹1,349 Cr | ₹1,377 Cr |
| Other Income | ₹76 Cr | ₹121 Cr | ₹64 Cr | ₹299 Cr | ₹223 Cr |
| Interest | ₹358 Cr | ₹451 Cr | ₹504 Cr | ₹308 Cr | ₹206 Cr |
| Depreciation | ₹658 Cr | ₹654 Cr | ₹618 Cr | ₹409 Cr | ₹307 Cr |
| Profit Before Tax | ₹1,526 Cr | ₹1,187 Cr | ₹562 Cr | ₹931 Cr | ₹1,088 Cr |
| Profit After Tax | ₹1,252 Cr | ₹1,025 Cr | ₹436 Cr | ₹678 Cr | ₹934 Cr |
| Consolidated Net Profit | ₹1,252 Cr | ₹1,025 Cr | ₹436 Cr | ₹678 Cr | ₹934 Cr |
| Earnings Per Share (Rs) | ₹73.97 | ₹60.55 | ₹25.78 | ₹40.07 | ₹55.16 |
| PAT Margin (%) | 8.41 | 6.85 | 3.00 | 6.02 | 15.94 |
| ROE(%) | 23.49 | 21.47 | 9.34 | 15.12 | 23.80 |
| ROCE(%) | 17.63 | 15.28 | 9.75 | 13.81 | 20.36 |
| Total Debt/Equity(x) | 0.84 | 1.21 | 1.28 | 1.40 | 0.58 |
Key Financials |
|
| Market Cap : | ₹ 52,456.2 Cr |
| Revenue (TTM) : | ₹ 8,083.0 Cr |
| Net Profit(TTM) : | ₹ 1,261.0 Cr |
| EPS (TTM) : | ₹ 74.5 |
| P/E (TTM) : | 41.6 |
| Peers & Returns | 1W | 1M | 1Y |
| TORRENT PHARMACEUTICALS | 0.2% | 1.5% | 7.4% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -0.3% | 47.1% |
| DIVIS LABORATORIES | 1.7% | 7.3% | 53.8% |
| DR REDDYS LABORATORIES | -1.9% | 4.5% | -9% |
| CIPLA | 1.5% | 5.5% | 19.6% |
| GLAND PHARMA | -1.6% | 2.6% | NA |
| PIRAMAL ENTERPRISES | 5.6% | 6.6% | 95.6% |
| CADILA HEALTHCARE | 1.6% | 3.3% | 37.2% |
| ALKEM LABORATORIES | 5.7% | 4.8% | 38.4% |
| Revenues | |
|---|---|
| Y-o-Y | 0.83 % |
| 5 Yr CAGR | 8.31 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2021 | ₹8,005 Cr | 0.83 | |
| Mar2020 | ₹7,939 Cr | 3.47 | |
| Mar2019 | ₹7,673 Cr | 28.96 | |
| Mar2018 | ₹5,950 Cr | 2.31 | |
| Mar2017 | ₹5,816 Cr | - | |
| Operating Profit | |
|---|---|
| Y-o-Y | 13.65 % |
| 5 Yr CAGR | 15.68 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2021 | ₹2,467 Cr | 13.65 | |
| Mar2020 | ₹2,170 Cr | 9.81 | |
| Mar2019 | ₹1,976 Cr | 46.49 | |
| Mar2018 | ₹1,349 Cr | -2.03 | |
| Mar2017 | ₹1,377 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 12.69 % |
| 5 Yr CAGR | 6.80 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2021 | 30.81% | 12.69 | |
| Mar2020 | 27.34% | 6.13 | |
| Mar2019 | 25.76% | 13.58 | |
| Mar2018 | 22.68% | -4.22 | |
| Mar2017 | 23.68% | - | |
| Profit After Tax(PAT) | |
|---|---|
| Y-o-Y | 22.17 % |
| 5 Yr CAGR | 7.61 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2021 | ₹1,252 Cr | 22.17 | |
| Mar2020 | ₹1,025 Cr | 134.88 | |
| Mar2019 | ₹436 Cr | -35.66 | |
| Mar2018 | ₹678 Cr | -27.36 | |
| Mar2017 | ₹934 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 22.77 % |
| 5 Yr CAGR | -14.77 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2021 | 8.41 % | 22.77 | |
| Mar2020 | 6.85 % | 128.33 | |
| Mar2019 | 3 % | -50.17 | |
| Mar2018 | 6.02 % | -62.23 | |
| Mar2017 | 15.94 % | - | |
| EPS | |
|---|---|
| Y-o-Y | 22.16 % |
| 5 Yr CAGR | 7.61 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2021 | ₹74 | 22.16 | |
| Mar2020 | ₹61 | 134.87 | |
| Mar2019 | ₹26 | -35.66 | |
| Mar2018 | ₹40 | -27.36 | |
| Mar2017 | ₹55 | - | |
| ROCE | |
|---|---|
| Y-o-Y | 15.38 % |
| 5 Yr CAGR | -3.54 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2021 | 17.63% | 15.38 | |
| Mar2020 | 15.28% | 56.72 | |
| Mar2019 | 9.75% | -29.40 | |
| Mar2018 | 13.81% | -32.17 | |
| Mar2017 | 20.36% | - | |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE MOMENTUM | 2.8% | 7.2% | 41.8% |
| S&P BSE LARGE MIDCAP | 2.5% | 7.6% | 56.6% |
| S&P BSE 100 | 2.5% | 7.4% | 55.5% |
| S&P BSE CARBONEX | 2.5% | 7.2% | 54.9% |
| S&P BSE 250 LARGEMIDCAP | 2.5% | 7.6% | 57.8% |
| S&P BSE 200 | 2.5% | 7.6% | 57.5% |
| S&P BSE 100 LARGECAP TMC | 2.5% | 7.4% | 55.3% |
| S&P BSE 500 | 2.5% | 7.7% | 59.1% |
| S&P BSE ALLCAP | 2.4% | 7.7% | 60.1% |
| S&P BSE MID CAP | 2.4% | 9.8% | 69.4% |
| S&P BSE MIDSMALLCAP | 2.2% | 8.8% | 76.8% |
| S&P BSE SENSEX NEXT 50 | 2.1% | 8.9% | 59.4% |
| S&P BSE MIDCAP SELECT INDEX | 1.2% | 7.7% | 63.3% |
| S&P BSE HEALTHCARE | 0.4% | 1.9% | 30.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 200 | 2.5% | 7.8% | 57.6% |
| NIFTY LARGE MIDCAP 250 | 2.5% | 8.3% | 63.2% |
| NIFTY 100 | 2.5% | 7.5% | 55.4% |
| NIFTY 500 | 2.5% | 7.8% | 59.1% |
| NIFTY500 MULTICAP 50:25:25 | 2.4% | 8.1% | NA |
| NIFTY ALPHA LOW-VOLATILTY 30 | 2.1% | 8.2% | 47.8% |
| NIFTY NEXT 50 | 1.7% | 8.3% | 57.7% |
| NIFTY PHARMA | 1.4% | 3.3% | 16.7% |
| NIFTY HEALTHCARE | 0.6% | 1.5% | NA |
The current share price of TORRENT PHARMACEUTICALS is ₹ 3,100.3.
The share price returns of TORRENT PHARMACEUTICALS are as under:
1 Week : 0.2%
1 Month : 1.5%
1 Year : 7.4%
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure